The Orphan Drug Act : implementation and impact / Department of Health and Human Services, Office of Inspector General.

Orphan Drug Amendments of 1992 : report together with additional views (to accompany S. 2060).
Published: (1992)

Orphan Drug Amendments of 1992 : report together with additional views (to accompany S. 2060).
Published: (1992)

Orphan Drug Amendments of 1994 : report together with additional views (to accompany S. 1981).
Published: (1994)

Orphan Drug Amendments of 1994 : report together with additional views (to accompany S. 1981).
Published: (1994)

Orphan Drug Amendments of 1991 hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, second session, on S. 2060 ... Tuesday, March 3, 1992.
Published: (1992)

Rare diseases and orphan drugs keys to understanding and treating the common diseases
by: Berman, Jules J.
Published: (2014)

Orphan products development : Office of Orphan Products Development.
Published: (1998)

Anticompetitive Abuse of the Orphan Drug Act invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992.
Published: (1992)

Orphan Drug Act Amendments of 1994 : report together with dissenting views (to accompany H.R. 4865) (including cost estimate of the Congressional Budget Office).
Published: (1994)

Orphan Drug Act Amendments of 1994 : report together with dissenting views (to accompany H.R. 4865) (including cost estimate of the Congressional Budget Office).
Published: (1994)

[Henry A. Waxman talks about the need for legislation to support research on "orphan drugs", those which could not repay the pharmaceutical research in the open market].
Published: (1983)

Orphan vaccines : bridging the gap : Palm Cove, Queensland, Australia, 25th-29th August 2001
Published: (2002)

Orphan drug reauthorization : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994.
Published: (1994)

Orphan drug reauthorization hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994.
Published: (1994)

Orphan drug reauthorization : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994.
Published: (1994)

Cooperative approaches to research and development of orphan drugs : proceedings of a conference in New York, New York, April 9 and 10, 1984
Published: (1985)

Rare diseases and orphan products : accelerating research and development
Published: (2010)

Expert opinion on orphan drugs
Published: (2013)

Orphan Drug Act : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 7, 1990.
Published: (1990)

Orphan Drug Act : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 7, 1990.
Published: (1990)

Orphan Drug Act : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 7, 1990.
Published: (1990)

Anticompetitive Abuse of the Orphan Drug Act : invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992.
Published: (1992)

Anticompetitive Abuse of the Orphan Drug Act : invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992.
Published: (1992)

Anticompetitive Abuse of the Orphan Drug Act : invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992.
Published: (1992)

Orphan drugs
by: Anderson, Kenneth, 1921-2001
Published: (1987)

Orphan Drug Amendments of 1990 : report (to accompany H.R. 4638) (including cost estimate of the Congressional Budget Office).
Published: (1990)

Orphan Drug Amendments of 1990 : report (to accompany H.R. 4638) (including cost estimate of the Congressional Budget Office).
Published: (1990)

Orphans : file of clippings and miscellanea.
Published: (1970)

Breakthrough business models : drug development for rare and neglected diseases and individualized therapies : workshop summary
Published: (2009)

The orphan train in Michigan, 1854-1927
Published: (2002)

Report of the National Conference on Orphan Drugs : the path to promise : May 18-19, 1988, George Washington University, Washington, D.C. / [sponsored jointly by] the National Institutes of Health and the Pharmaceutical Manufacturers Association.
Published: (1988)

The orphan trains
by: Johnson, Kristin F., 1968-
Published: (2012)

The orphan trains placing out in America
by: Holt, Marilyn Irvin, 1949-
Published: (1992)

The orphan trains : placing out in America
by: Holt, Marilyn Irvin, 1949-
Published: (1992)

Small market drugs, big price tags :are drug companies exploiting people with rare disease? : hearing before the Joint Economic Committee, Congress of the United States, One Hundred Tenth Congress, second session, July 24, 2008.
Published: (2009)

Small market drugs, big price tags : are drug companies exploiting people with rare disease? : hearing before the Joint Economic Committee, Congress of the United States, One Hundred Tenth Congress, second session, July 24, 2008.
Published: (2009)